Search - tctmd.com

Displaying 141 - 160 of 786

Sort: Relevancy | Date

News Industry News

Micell Technologies Announces Completion of Enrollment in MiStent Randomized Trial Against Xience

December 08, 2015

News Daily News

Surgery Common in Stented Patients But Newer Stents Appear to Reduce Potential Risks

Michael O'Riordan

December 07, 2015

News Daily News

Residual Dissection After DCB Treatment for De Novo CAD Generally Resolves

Caitlin E. Cox

November 26, 2015

News Daily News

CAD Complexity Does Not Affect Dominance of Newer vs Older DES

Todd Neale

November 16, 2015

Presentation TCT 2015

A Randomized Comparison Among Drug Eluting Balloon, Drug Eluting Stents, and Conventional Balloon Angioplasty for Lesions in the Distal Internal Pudendal Artery in Patients with Erectile Dysfunction: The Perfect-3 Study

Presenter: Andrea Abizaid, Daniel Burkhoff, Tzung-Dau Wang

October 14, 2015

News Industry News

Study From China Examines Clinical Outcomes Of Two Drug-Eluting Stents With Bioresorbable Polymers Employing Different Elution And Absorption Rates

October 14, 2015

News Industry News

Randomized Trial Of Diabetic Patients In India Finds Paclitaxel-Eluting Stents Failed To Meet Non-Inferiority Compared To Everolimus-Eluting Stents

October 14, 2015

News Industry News

Plaque Modification With Scoring Balloon Improves Angiographic Outcomes In Patients Treated With A Drug-Coated Balloon For Drug-Eluting Stent Restenosis

October 14, 2015

News Conference News TCT 2015

ISAR-DESIRE 4: Scoring Balloon Predilation Effective at 1 Year in Patients With DES Restenosis

October 14, 2015

Presentation TCT 2015

TCT 66: Long-term Clinical Outcomes of Percutaneous Coronary Intervention Using Drug-Eluting Stent for Native Coronary Chronic Total Occlusion

Presenter: Sigmund Silber, Philip M. Urban, Pil Hyung Lee

October 13, 2015

Presentation TCT 2015

TCT 65: Two-Year Outcomes in Real-World Patients Treated With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent in the PROMUS Element Plus US Postapproval Study (PE-Plus PAS)

Presenter: Sigmund Silber, Philip M. Urban, David E. Kandzari

October 13, 2015

Presentation TCT 2015

TCT 64: Incidence, Predictors, and Impact of Postdischarge Bleeding Compared to Myocardial Infarction After Percutaneous Coronary Intervention

Presenter: Sigmund Silber, Philip M. Urban, Philippe Généreux

October 13, 2015

Presentation TCT 2015

TCT 15: Multislice Computed Tomography Assessment of Absorb Bioresorbable Vascular Scaffold in Comparison With Metallic Drug-Eluting Stents Data From the ABSORB Japan Trial

Presenter: Stephen G. Ellis, Lorenz Raber, Kengo Tanabe

October 13, 2015

Presentation TCT 2015

TCT 63: One-Year Results of the REMEDEE Registry Clinical Outcomes After Deployment of the Abluminal Sirolimus-Coated Bioengineered Stent in a Multicenter, Prospective Postmarket Registry

Presenter: Sigmund Silber, Philip M. Urban, Robert de Winter

October 13, 2015

Presentation TCT 2015

TCT 47: Comparative Optical Coherent Tomographic Analysis of In-Stent Neoatherosclerosis Between First- and Second-Generation Drug-Eluting Stents

Presenter: Stephan Achenbach, Marc D. Feldman, Mineok Chang

October 13, 2015

Presentation TCT 2015

TCT 62: Predicting Value of Platelet Reactivity on Bleeding and Major Adverse Cardiac Events in Eastern Asian Percutaneous Coronary Intervention Patients

Presenter: Sigmund Silber, Philip M. Urban, Wenyao Wang

October 13, 2015

Presentation TCT 2015

TCT 19: Two-Year Clinical Outcomes and Chest Pain in 1,811 All-Comer Patients, Treated for Bifurcated Versus Nonbifurcated Lesions With Highly Deliverable Drug-Eluting Coronary Stents

Presenter: Eric A. Cohen, Truls Råmunddal, Liefke van der Heijden

October 13, 2015

Presentation TCT 2015

TCT 60: Long Coronary Lesions Treated With a Bioresorbable-Polymer Drug-Eluting Stent Experience From eNOBORI Registry

Presenter: Sigmund Silber, Philip M. Urban, Evgeny Kretov

October 13, 2015

Presentation TCT 2015

TCT 59: The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After DES The ADAPT-DES study

Presenter: Sigmund Silber, Philip M. Urban, Sorin J. Brener

October 13, 2015

News Conference News TCT 2015

Trial Results Often Struggle to Keep Pace With Evolving Technology

Nicole Lou

October 13, 2015

Advertisement

Micell Technologies Announces Completion of Enrollment in MiStent Randomized Trial Against Xience

Surgery Common in Stented Patients But Newer Stents Appear to Reduce Potential Risks

Residual Dissection After DCB Treatment for De Novo CAD Generally Resolves

CAD Complexity Does Not Affect Dominance of Newer vs Older DES

A Randomized Comparison Among Drug Eluting Balloon, Drug Eluting Stents, and Conventional Balloon Angioplasty for Lesions in the Distal Internal Pudendal Artery in Patients with Erectile Dysfunction: The Perfect-3 Study

Study From China Examines Clinical Outcomes Of Two Drug-Eluting Stents With Bioresorbable Polymers Employing Different Elution And Absorption Rates

Randomized Trial Of Diabetic Patients In India Finds Paclitaxel-Eluting Stents Failed To Meet Non-Inferiority Compared To Everolimus-Eluting Stents

Plaque Modification With Scoring Balloon Improves Angiographic Outcomes In Patients Treated With A Drug-Coated Balloon For Drug-Eluting Stent Restenosis

ISAR-DESIRE 4: Scoring Balloon Predilation Effective at 1 Year in Patients With DES Restenosis

TCT 66: Long-term Clinical Outcomes of Percutaneous Coronary Intervention Using Drug-Eluting Stent for Native Coronary Chronic Total Occlusion

TCT 65: Two-Year Outcomes in Real-World Patients Treated With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent in the PROMUS Element Plus US Postapproval Study (PE-Plus PAS)

TCT 64: Incidence, Predictors, and Impact of Postdischarge Bleeding Compared to Myocardial Infarction After Percutaneous Coronary Intervention

TCT 15: Multislice Computed Tomography Assessment of Absorb Bioresorbable Vascular Scaffold in Comparison With Metallic Drug-Eluting Stents Data From the ABSORB Japan Trial

TCT 63: One-Year Results of the REMEDEE Registry Clinical Outcomes After Deployment of the Abluminal Sirolimus-Coated Bioengineered Stent in a Multicenter, Prospective Postmarket Registry

TCT 47: Comparative Optical Coherent Tomographic Analysis of In-Stent Neoatherosclerosis Between First- and Second-Generation Drug-Eluting Stents

TCT 62: Predicting Value of Platelet Reactivity on Bleeding and Major Adverse Cardiac Events in Eastern Asian Percutaneous Coronary Intervention Patients

TCT 19: Two-Year Clinical Outcomes and Chest Pain in 1,811 All-Comer Patients, Treated for Bifurcated Versus Nonbifurcated Lesions With Highly Deliverable Drug-Eluting Coronary Stents

TCT 60: Long Coronary Lesions Treated With a Bioresorbable-Polymer Drug-Eluting Stent Experience From eNOBORI Registry

TCT 59: The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After DES The ADAPT-DES study

Trial Results Often Struggle to Keep Pace With Evolving Technology

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content